Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anthrax”

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07268612
What this trial is testing

Evaluation of Clinical Benefit and Safety Following CYFENDUS Administration for Post-Exposure Prophylaxis of Anthrax Disease.

Who this might be right for
Anthrax
Emergent BioSolutions 250
Not applicableStudy completedNCT01653392
What this trial is testing

BioThrax® (Anthrax) Vaccine in Pregnancy Registry

Who this might be right for
Pregnancy ComplicationsPregnancy OutcomeCongenital Abnormalities
Emergent BioSolutions 98
Testing effectiveness (Phase 2)Looking for participantsNCT07201311
What this trial is testing

Combined Gastrointestinal Decontamination in Acute Severe Poisoning

Who this might be right for
Severe Poisoning With Cardiotropic or Psychotropic DrugAdmission to Intensive Care
Assistance Publique - Hôpitaux de Paris 200
Early research (Phase 1)Study completedNCT03352466
What this trial is testing

NasoShield Study of Safety and Immunogenicity

Who this might be right for
Healthy Volunteers
Altimmune, Inc. 145
Early research (Phase 1)Study completedNCT00057525
What this trial is testing

A New Anthrax Vaccine Administered by the Intramuscular (IM) Route in Healthy Adults

Who this might be right for
Anthrax
DynPort Vaccine Company LLC, A GDIT Company 70
Not applicableStudy completedNCT00031291
What this trial is testing

Plasmapheresis of Anthrax-Vaccinated Subjects for Production of Anthrax Immune Globulin

Who this might be right for
Anthrax
National Institutes of Health Clinical Center (CC) 400
Testing effectiveness (Phase 2)Study completedNCT00170456
What this trial is testing

Phase II Study of Range and Schedule of rPA Doses

Who this might be right for
Prevention of Bacillus Anthracis (Anthrax) Infection
PharmAthene UK Limited 415
Not applicableStudy completedNCT03498027
What this trial is testing

Febrile Whole Blood Specimen Collection and Testing

Who this might be right for
Febrile InfectionAnthrax
MRI Global 97
Early research (Phase 1)Study completedNCT00103467
What this trial is testing

Trial to Evaluate the Safety and Immunogenicity of an Anthrax Recombinant Protective Antigen Vaccine

Who this might be right for
Prevention of Anthrax Infection
VaxGen 100
Early research (Phase 1)Study completedNCT01202695
What this trial is testing

Safety and Pharmacokinetics Study of Human Monoclonal Antibody (AVP-21D9)

Who this might be right for
Anthrax
Emergent BioSolutions 50
Early research (Phase 1)Study completedNCT02655549
What this trial is testing

Anthrax Vaccines Px563L and RPA563 in Healthy Adult Subjects

Who this might be right for
Anthrax
Pfenex, Inc 54
Early research (Phase 1)Study completedNCT02934607
What this trial is testing

Assess How Much Drug Reaches the Blood When Given From Symbicort pMDI With Spacer Compared to That of Symbicort pMDI Without Spacer in Healthy Volunteers

Who this might be right for
Study is Being Conducted in Healthy Volunteers
AstraZeneca 50
Testing effectiveness (Phase 2)Study completedNCT01268683
What this trial is testing

Glyburide Advantage in Malignant Edema and Stroke Pilot

Who this might be right for
Ischemic Stroke
Remedy Pharmaceuticals, Inc. 10
Early research (Phase 1)Study completedNCT00063843
What this trial is testing

Anthrax-rPA: Safety, Tolerability, Immunogenicity

Who this might be right for
Anthrax
National Institute of Allergy and Infectious Diseases (NIAID) 80
Not applicableUnknownNCT06365073
What this trial is testing

A Case-control Study on the Clinical Characteristics of 28-day and 90-day Death From Severe Anthrax

Who this might be right for
Anthrax
Qin Ning 80
Post-approval studies (Phase 4)Not Yet RecruitingNCT06858436
What this trial is testing

SGLT2 Inhibitor Utilization Re-perfusion Therapy

Who this might be right for
Acute Ischemic Stroke From Large Vessel Occlusion
Taichung Veterans General Hospital 150
Early research (Phase 1)Study completedNCT01932242
What this trial is testing

Safety, Tolerability and PK of Repeat Administration of Intravenous ETI-204 in Adult Volunteers

Who this might be right for
Inhalational Anthrax
Elusys Therapeutics 70
Early research (Phase 1)Study completedNCT01932437
What this trial is testing

Intramuscular Dose-Escalation Study With ETI-204 in Adult Volunteers

Who this might be right for
Inhalational Anthrax
Elusys Therapeutics 36
Early research (Phase 1)Study completedNCT02657512
What this trial is testing

Effect of Activated Charcoal on Rivaroxaban Pharmacokinetics in Healthy Subjects

Who this might be right for
Healthy
Centre Hospitalier Universitaire de Saint Etienne 12
Early research (Phase 1)Study completedNCT01280175
What this trial is testing

Foster With or Without Charcoal Block or Aerochamber Plus

Who this might be right for
Healthy Volunteers
Chiesi Farmaceutici S.p.A. 13
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation